Phase 2 study of cobimetinib in combination with vemurafenib in active melanoma brain metastases (coBRIM-B) Meeting Abstract

  

Authors:	Yee, M. K.; Lin, Y.; Gorantla, V. C.; Butterfield, L. H.; Kluger, H. M.; Chapman, P. B.; Gangadhar, T. C.; Milhem, M. M.; Pavlick, A. C.; Amaravadi, R. K.; Schuchter, L. M.; Tarhini, A. A.; Kirkwood, J. M.; Tawbi, H. A. H.
Abstract Title:	Phase 2 study of cobimetinib in combination with vemurafenib in active melanoma brain metastases (coBRIM-B)
Meeting Title:	51st Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	33
Issue:	15 Suppl.
Meeting Dates:	2015 May 29-Jun 2
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2015-05-20
Language:	English
ACCESSION:	WOS:000358036904886
PROVIDER:	wos
Notes:	Meeting Abstract: TPS9088 -- Source: Wos